Sunday, August 3, 2014

More Veterinary Sales Jobs

Update to Countries Viewing the Blog

Add Albania and Reunion

Albania
Algeria
Antigua and Barbuda
Argentina
Armenia
Australia
Austria
Azerbaijan
Bahamas
Bangladen
Bangladesh
Barbados
Belarus
Belgium
Benin
Bermuda
Bosina & Herzegovina
Brazil
Bulgaria
Burkina Faso
Canada
Cameroon
Cayman Islands 
Chile
China
Columbia
Congo (Republic)
Costa Rica
Cote d'lvoire
Croatia
Cyprus
Czech Republic
Denmark
Dominica
Dominican Republic

AFDO Presentations Related to to Antibiotics in Agriculture--Antimicrobial resistance is one of the most significant challenges facing modern public health

Pharmacists Here Are Photos of 483 Violations the FDA Has Observed at Compounding Pharmacies; Consumers You may Want to Review Also

Compounding Pharmacies - Erika Butler, Drug Specialist, U.S. Food and Drug Administration

Even if you Don't Register as an Outsourcing Facility with the FDA, the FDA May Still Be Knocking on Your Door Soon


•FDA has been conducting inspections of compounding pharmacies for cause (in response to serious adverse event reports, reports of quality problems, and state requests)

•FDA has also been conducting proactive inspections to identify pharmacies with deficient sterile practices

•FDA will continue these efforts as available resources permit
quoted from - Compounding Pharmacies - Erika Butler, Drug Specialist, U.S. Food and Drug Administration

118th Annual Association of Food and Drug Organization (AFDO) Education Conference Had A lot of Presentations on Compounding Pharmacies from FDA officials and Others--View Presentations Here

Justices silent over execution drug secrecy

WASHINGTON (AP) — No U.S. Supreme Court justice has emerged as a principled opponent of the death penalty, even as the number of executions annually in the country has dropped by more than half over the past 15 years and the court has barred states from killing juveniles and the mentally disabled.
No one on the Supreme Court objected publicly when the justices voted to let Arizona proceed with the execution of Joseph Wood, who unsuccessfully sought information about the drugs that would be used to kill him. Inmates in Florida and Missouri went to their deaths by lethal injection in the preceding weeks after the high court refused to block their executions. Again, no justice said the executions should be stopped.
"They're all voting to kill them, every so often. They do it in a very workmanlike, technocratic fashion," Stephen Bright, a veteran death penalty lawyer in Georgia, said of the high court.
Wood's execution on July 23 was the 26th in the United States this year and the third in which prisoners took much longer than usual to die. Wood, convicted of killing his estranged girlfriend and her father, was pronounced dead nearly two hours after his execution began, and an Associated Press reporter was among witnesses who said Wood appeared to gasp repeatedly, hundreds of times in all, before he died.
Justice Ruth Bader Ginsburg said she and her colleagues are aware of what happened in Arizona, though she declined to say how the court would rule on a plea to stop the next scheduled execution — of Michael Worthington on Wednesday in Missouri.
continue to read here

Saturday, August 2, 2014

Questions all Veterinarians Should Ask A Compounding Pharmacists; Pet Owners May also want to ask these Questions

Questions to ask your compounder:
• What FDA approved drug will you use to compound the product that I

have prescribed?
• Do you have this prescription available for shipment now or do you
 

formulate each prescription individually?
• What training have you received on compounding drugs for use in


veterinary medicine?
• How will you determine the expiration date for my compounded


prescription?
• How do you handle any reports of adverse events associated with the


products you compound?

quoted from here

Types of Animal Compounding Activities that May Result in FDA Enforcement Action; If you have already violated any of these, you should consult an attorney for advice


 
What types of compounding activities could result in FDA enforcement action?



• Compounding a veterinary drug if an approved veterinary or human drug

exists to treat the diagnosed condition,



• Compounding drug products that are copies of commercially available FDA approved

drug products,



• Compounding when there is no valid Veterinarian-Client-Patient relationship,



• Compounding from unapproved drug products or bulk drug substances,



• Compounding veterinary drugs in anticipation of receiving prescriptions,



• Compounding of drug products in bulk using commercial scale manufacturing

equipment,



• Compounding drugs for use when the health of the patient is not threatened or

suffering or death may result from failure to treat,



• Compounding a veterinary drug from a human drug that has been removed


from marketing due to human safety concerns. For example, cisapride, which


is only available under a restricted distribution system.



• Compounding from a human drug for food-producing animals if an approved


food animal drug can be used. Due to food-safety issues, the FDA prohibits


the extralabel use of some drugs in food-producing animals. A list of these


restricted drugs can be found in 21 CFR 530.41.



• Offering compounded drug products at wholesale to other state-licensed


persons or commercial entities for resale,



• Labeling a compounded drug with a withdrawal time established by the

pharmacist and not the prescribing veterinarian,

 • Compounding veterinary drugs without regard to state pharmacy laws

quoted from here

Observation: In the last couple of months, It is unbelievable how many statements, advertisements, etc. appear to be flaunting that compounding pharmacists and pharmacies are violating state and federal la almost in a catch me if you can manner.. These may turn out to be the best evidence for the FDA to use for criminal prosecutions and civil enforcement.